GGrantIndex
Sort

40,608 grants matching prostate cancer

High resolution volumetric MRI for prostate cancer active surveillance

$373,652
Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2017 · CA

Epigenetics Landscape of Chronic Kidney Disease

$373,500
Katalin Susztak · Albert Einstein College Of Medicine · R01 · FY2009 · DK

PROSTATE CANCER ASSOCIATED T-CELL COINHIBITORY MOLECULES:POTENTIAL NEW TUMOR EVASION PATHWAYS AND THERAPEUTIC TARGETS

$373,500
Albert Einstein College Of Medicine · · FY2010 · Department of the Army

HIGH THROUGHPUT IDENTIFICATION OF NOVEL GENETIC PATHWAYS LEADING TO AR ACTIVSTION IN PROSTATE CANCER CELLS

$373,500
Ordway Research Institute, Inc. · · FY2008 · Department of the Army

CANCER SERO EPIDEMIOLOGY AMONG THE JAPANESE IN HAWAII

$373,492
Kuakini Medical Center · R01 · FY2000 · CA

Mechanisms of Carcinogenesis in BRCA2 Mutant Cells

$373,468
University Of Colorado Denver · R01 · FY2002 · CA

Towards Understanding Prostate Cancer Heterogeneity

$373,464
Mark A. Rubin · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · CA

(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu

$373,436
Lily Y Jan · University Of California, San Francisco · R01 · FY2017 · CA

(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu

$373,436
Lily Y Jan · University Of California, San Francisco · R01 · FY2016 · CA

Hardwiring Mechanism into Predicting Cancer Phenotypes by Computational Learning

$373,431
Luigi Marchionni · Johns Hopkins University · R01 · FY2019 · CA

Urinary biomarkers for prostate cancer diagnosis and risk assessment

$373,420
Wen-Yee Lee · University Of Texas El Paso · SC1 · FY2019 · CA

Developmental Funds

$373,395
Ralph W. De Vere White · University Of California At Davis · P30 · FY2016 · CA

Early Cancer Detection & Prognosis through Glycomics

$373,354
Milos V Novotny · Trustees Of Indiana University · U01 · FY2008 · CA

Kallikrein-Targeted Alpha-Particle Therapy of Late-Stage Prostate Cancer

$373,340
Daniel Lyndon Jaffe Thorek · Johns Hopkins University · R01 · FY2017 · CA

Collaborative Systems for Analyzing Tissue Microarrays

$373,339
David J Foran · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2011 · CA

Role of Tumor Stem Cells Recurrent Prostate Cancer

$373,257
Gary Smith · Univ Of North Carolina Chapel Hill · P01 · FY2010 · CA

The Role of ADAM15 in Prostate Tumor Intravazation and Metastasis

$373,251
Mark L Day · University Of Michigan At Ann Arbor · R01 · FY2013 · CA

Whole Genome Association Study of Mammographic Density

$373,231
Rulla M Tamimi · Brigham And Women'S Hospital · R01 · FY2012 · CA

Regulation of mammary branching morphogenesis by Slit/Robo1 signaling

$373,220
Lindsay E Hinck · University Of California Santa Cruz · R01 · FY2012 · GM

Targeting AR variants in advanced prostate cancer

$373,205
Allen C Gao · University Of California At Davis · R01 · FY2019 · CA

Therapeutic targeting steroid sulfatase for advanced prostate cancer

$373,143
Allen C Gao · University Of California At Davis · R01 · FY2021 · CA

(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu

$373,133
Lily Y Jan · University Of California, San Francisco · R01 · FY2015 · CA

Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers

$373,062
Richard B Silverman · Northwestern University · R01 · FY2025 · CA

SOUTHWEST ONCOLOGY GROUP

$373,015
Wayne State University · U10 · FY2003 · CA

Lung Cancer Drivers and Dependencies as Therapeutic Targets

$372,966
Scott W Lowe · Sloan-Kettering Inst Can Research · P01 · FY2012 · CA